powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1841440674
Tsewang Tashi
M.D.
Hematology-Oncology
Salt Lake City,
UT
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
89.8
Quality
91.5
Cost
74.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.62%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
225
Unique beneficiaries
—
Total services
571
Distinct HCPCS
8
Medicare payment
$29K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 55 Hematology-Oncology providers in UT — below median (cohort median 631).
PRESCRIBING · PART D · 2024
Total Rx claims
491
Beneficiaries
—
Total drug cost
$3.4M
Distinct drugs
11
Brand share
35.0%
Top prescribed drugs
Hydroxyurea
188 claims
Ruxolitinib Phosphate
78 claims
Acyclovir
72 claims
Avapritinib
37 claims
Allopurinol
30 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$13K
Payment records
5
By payment type
Consulting Fee
$13K
Food and Beverage
$66